2633.HK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 09:15):

Stats
Dagens volum	118 000
Gjennomsnittsvolum	528 201
Markedsverdi	1.11B
EPS	HKD0.0272 ( 2023-06-15 )
Last Dividend	HKD0.0238 ( 2023-08-15 )
Next Dividend	HKD0 ( N/A )
P/E	5.09
ATR14	HKD0 (0.00%)

Jacobson Pharma Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Jacobson Pharma Økonomi

Annual	2022
Omsetning:	HKD1.79B
Bruttogevinst:	HKD747.17M (41.84 %)
EPS:	HKD0.130

FY	2022
Omsetning:	HKD1.79B
Bruttogevinst:	HKD747.17M (41.84 %)
EPS:	HKD0.130

FY	2022
Omsetning:	HKD1.60B
Bruttogevinst:	HKD620.52M (38.89 %)
EPS:	HKD0.0927

FY	2021
Omsetning:	HKD1.45B
Bruttogevinst:	HKD561.08M (38.80 %)
EPS:	HKD0.0900

Financial Reports:

No articles found.

Jacobson Pharma Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0.0548 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.0238 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Jacobson Pharma Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.45 - Stable (11.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.00800	2017-01-09
Last Dividend	HKD0.0238	2023-08-15
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	HKD0.264	--
Avg. Dividend % Per Year	0.00%	--
Score	3.52	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.45
Div. Directional Score	7.93	--

Next Divdend (Est)
(2024-07-22)

HKD0.0247 Estimate 3.60 %

Dividend Stability

0.29 Very Poor

Dividend Score

3.52

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2230.HK	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%
1243.HK	Ex Dividend Junior	2023-08-25	Annually	0.00%
0308.HK	Ex Dividend Junior	2023-09-18	Annually	0.00%
3993.HK	Ex Dividend Junior	2023-06-29	Annually	0.00%
1800.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%
0836.HK	Ex Dividend Knight	2023-09-05	Semi-Annually	0.00%
0002.HK	Ex Dividend Knight	2023-09-04	Quarterly	0.00%
2382.HK	Ex Dividend Junior	2023-05-30	Annually	0.00%
1373.HK	Ex Dividend Knight	2023-10-04	Semi-Annually	0.00%
0435.HK	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.143	1.500	7.14	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0604	1.200	7.99	9.59	[0 - 0.3]
returnOnEquityTTM	0.0959	1.500	-0.0452	-0.0679	[0.1 - 1]
payoutRatioTTM	0.621	-1.000	3.79	-3.79	[0 - 1]
currentRatioTTM	1.283	0.800	8.58	6.87	[1 - 3]
quickRatioTTM	1.009	0.800	8.77	7.01	[0.8 - 2.5]
cashRatioTTM	0.788	1.500	6.73	10.00	[0.2 - 2]
debtRatioTTM	0.329	-1.500	4.52	-6.79	[0 - 0.6]
interestCoverageTTM	3.30	1.000	9.89	9.89	[3 - 30]
operatingCashFlowPerShareTTM	0.330	2.00	9.89	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.271	2.00	9.86	10.00	[0 - 20]
debtEquityRatioTTM	0.574	-1.500	7.70	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.421	1.000	6.32	6.32	[0.2 - 0.8]
operatingProfitMarginTTM	0.182	1.000	8.37	8.37	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.482	1.000	8.43	8.43	[0.2 - 2]
assetTurnoverTTM	0.422	0.800	-0.519	-0.415	[0.5 - 2]
Total Score				11.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	4.45	1.000	9.65	0	[1 - 100]
returnOnEquityTTM	0.0959	2.50	-0.0291	-0.0679	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.271	2.00	9.91	10.00	[0 - 30]
dividendYielPercentageTTM	8.71	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.330	2.00	9.89	10.00	[0 - 30]
payoutRatioTTM	0.621	1.500	3.79	-3.79	[0 - 1]
pegRatioTTM	0.111	1.500	-2.60	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.375	1.000	3.12	0	[0.1 - 0.5]
Total Score				4.45

Jacobson Pharma

Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. In addition, it engages in the trading of medical supplies; procurement of packaging materials; sale of healthcare and herbal products; research and development; and property holding activities. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.